Kidney RSS News Feeds

Nephrology

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Lennon R et al. - Rosiglitazone has a direct and protective effect on glucose uptake in wild-type human podocytes. This represents a novel mechanism by which PPAR-gamma agonists may improve podocyte function in diabetic nephropathy.

Exclusive Author Commentary
M. A. Saleem, 06/23/09

The podocyte is increasingly being seen as central to the pathogenesis of diabetic nephropathy. Insulin sensitivity in glomerular podocytes is a novel and important finding in the context of understanding the pathogenesis of diabetic nephropathy. A key question is whether this cellular insulin sensitivity is lost in type II diabetes, as is seen in other insulin sensitive tissues, and therefore whether drugs can improve this sensitivity. This study for the first time demonstrates that podocytes can become insulin resistant, and that the PPARgamma class of drugs counteracts the effect, and in themselves improve podocyte insulin sensitivity.

Today in Glomerular/Tubular Dz...keeping you current

Management of lupus nephritis - current perspectives
Indian Journal of Rheumatology , 12/15/09

A Possible Catalytic Role for NH4+ in Na+ Reabsorption across the Thick Ascending Limb
American Journal of Physiology: Renal Physiology, 12/14/09

Crystal sedimentation and stone formation
Urological Research - Urolithiasis, 12/14/09

Today in Nephropathies...keeping you current

Coccoid Helicobacter pylori exists in the palatine tonsils of patients with IgA nephropathy
Journal of Gastroenterology, 12/15/09

Caring for adolescent renal patients
Kidney International, 12/11/09

BK virus nephropathy: a pediatric nephrologists perspective
Transplantation Reviews, 12/07/09

Today in Pharmacology/kinetics...keeping you current

Effects of Delayed Rapamycin Treatment on Renal Fibrosis and Inflammation in Experimental Ischemia Reperfusion Injury
Transplantation Proceedings, 12/15/09

Management of lupus nephritis - current perspectives
Indian Journal of Rheumatology , 12/15/09

Acute Hemolysis After High-Dose Intravenous Immunoglobulin Therapy in Highly HLA Sensitized Patients
Clinical Journal of the American Society of Nephrology, 12/15/09